Search

Your search keyword '"Feldman, Michael"' showing total 182 results

Search Constraints

Start Over You searched for: Author "Feldman, Michael" Remove constraint Author: "Feldman, Michael" Publication Type Conference Materials Remove constraint Publication Type: Conference Materials
182 results on '"Feldman, Michael"'

Search Results

2. Abstract LB052: Cell cycle synchronization: Biomarker analysis in a phase I trial of alternating ribociclib and paclitaxel in advanced breast cancer

3. Abstract 2723: How BRCA1/2 mutations in TNBC affect TME and subsequently immune cell functions

6. Abstract A22: Homologous recombination deficiency negatively predicts for immune infiltration and antitumor immune activity in breast tumors with BRCA1/2 alterations

8. Abstract 3691: Analysis of germline BRCA1/2 mutation associated breast and ovarian tumors reveals distinct pathways of immunosuppression

9. Abstract 3736: Characterization of tumor cells and assessment of PD-L1 expression in pleural effusions of metastatic non-small cell lung cancer patients

10. Abstract A12: Analysis of tumor immunogenicity in germline BRCA1/2 mutation associated breast and ovarian cancers

13. Abstract A02: The origin and role of APC-like hybrid tumor-associated neutrophils in early-stage human lung cancer

16. Abstract LB-236: Self-renewal of CD133hi cells by IL6/Notch3 signaling regulates endocrine resistance in metastatic breast cancers

18. Abstract A056: Mechanisms of tumor response and resistance to radiation and dual checkpoint blockade in mice and patients

20. Abstract A52: Radiation and dual PD-L1 and CTLA4 checkpoint blockade non-redundantly improves tumor resistance, response, and immunity

23. Abstract 618: Comparison of mutational spectra in metastatic tumors and cell-free DNA in breast cancer patients

24. Abstract 1262: The transcription factor ATF4 regulates resistance to anoikis and promotes metastasis in fibrosarcoma via cooperative upregulation of Heme Oxygenase-1 with Nrf2

25. Abstract 2858: Radiation and dual immune checkpoint blockade overcome tumor resistance and distinctly improve immunity

26. Abstract CT114: A phase II trial of exemestane and ruxolitinib for aI-resistant ER+ breast cancer: Interim safety, efficacy, and biomarker analysis

35. Computer Aided Monitoring of Neoadjuvant Chemotherapy for Breast Cancer

37. Personalized Medicine In Malignant Mesothelioma: Can Thymidylate Synthase And Excision Repair Cross-Complementation Group 1 Predict Response To Chemotherapy?

Catalog

Books, media, physical & digital resources